Sasha Z Prisco, Lynn M Hartweck, Felipe Kazmirczak, Jenna B Mendelson, Stephanie L Deng, Satadru K Lahiri, Xander H T Wehrens, Kurt W Prins.Junctophilin-2 Regulates Mitochondrial Metabolism.Circulation. 2024 Aug 20;150(8):657-660. doi: 10.1161/CIRCULATIONAHA.123.064343. Epub 2024 Aug 19.

DL, Habel N, Sánchez-Quintana D, Winget J, Correa de Sa D, Lobel R, Thompson N, Infeld M, Meyer M. Bachmann Bundle Pacing Heart Rhythm. 2024 Mar 27:S1547-5271(24)02281-1. doi: 10.1016/j.hrthm.2024.03.1786

Duprez DA, Duval S, Hoke L, Florea N, Grandits G, Carlson C, Lee J, Cohn JN. Early cardiovascular structural and functional abnormalities as a guide to future morbid events. Eur J Prev Cardiol. 2020 Feb 4:2047487320901416. doi: 10.1177.,

Duprez DA, Gross MD, Ix JH, Peralta CA, Kizer JR, Shea S, Jacobs DR Jr. Collagen biomarkers are associated with decline in renal function independently of blood pressure and other cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis Study. J Hypertens. 2019;37(12):2398-2403. doi: 10.1097.

Van't Hof JR, Duval S, Oldenburg NC, Misialek JR, Eder MM, Jones C, Finnegan JR, Luepker RV. Low-dose aspirin for primary prevention of cardiovascular disease: Trends in use patterns among African American adults in Minnesota, 2015-2019. Prev Med. 2021 Jul;148:106589. doi: 10.1016/j.ypmed.2021.106589.,

Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, Harrison DG, Dikalov SI, Langberg J. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation. 2005 Aug 30;112(9):1266-73. doi: 10.1161/CIRCULATIONAHA.105.538108. PMID: 16129811.

Prins, KW, Rose, L, Archer, SL, Weir, EK, Pritzker, M, Olson, M, and Thenappan, T. 2019. Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension due to Chronic Lung Disease. JAHA, 8: e01146,

Prins, KW, Thenappan, T, Kalra, R, Weir, EK, Prtizker, M, and Archer, SL. 2019. Repurposing Medications for Pulmonary Arterial Hypertension: What’s Old is New Again. JAHA, 8:e011343,

Rose L*, K.W. Prins*, S.L. Archer, M. Pritzker, E.K. Weir, and T. Thenappan. 2019. Survival in Pulmonary Hypertension due to Chronic Lung Disease: Influence of low diffusion capacity of the lung for carbon monoxide. JHLT. 38: 145-1554. Law, M, Prins, KW, M. Olander, and J.M. Metzger. 2018. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency-mediated chronically increased cardiac calcium cycling in vivo. AJP Heart. 315: H1544-H1552 ,

Prins KW, Rose L, Archer SL, Pritzker M, Weir EK, Kazmirczak F, Misialek JR, Thenappan T. Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension. Am J Respir Crit Care Med. 2018 Jun 1;197(11):1496-1499. doi: 10.1164/rccm.201712-2405LE. PMID: 29360393; PMCID: PMC6005552.